{"id":"rebif-new-formulation-titrated","safety":{"commonSideEffects":[{"rate":"50-70%","effect":"Flu-like symptoms"},{"rate":"30-50%","effect":"Injection site reactions"},{"rate":"20-40%","effect":"Fatigue"},{"rate":"20-40%","effect":"Headache"},{"rate":"10-30%","effect":"Depression"}]},"_chembl":{"chemblId":"CHEMBL5283859","moleculeType":null,"molecularWeight":"347.92"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by stimulating the body's immune system to reduce inflammation in the central nervous system, thereby slowing the progression of the disease. Interferon beta-1a has been shown to decrease the frequency of relapses and slow the progression of disability in patients with multiple sclerosis.","oneSentence":"Rebif New Formulation Titrated is an interferon beta-1a formulation used to treat multiple sclerosis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:30:54.210Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Relapsing forms of multiple sclerosis"}]},"trialDetails":[{"nctId":"NCT00472797","phase":"PHASE3","title":"Rebif New Formulation (RNF) Quality of Life (QOL) Study","status":"COMPLETED","sponsor":"EMD Serono","startDate":"2007-04","conditions":"Relapsing Multiple Sclerosis","enrollment":232}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Rebif New Formulation Titrated","genericName":"Rebif New Formulation Titrated","companyName":"EMD Serono","companyId":"emd-serono","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Rebif New Formulation Titrated is used to treat relapsing forms of multiple sclerosis. It is a treatment option for patients with relapsing multiple sclerosis, as indicated by ClinicalTrials.gov.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}